http://www.cnr.it/ontology/cnr/individuo/prodotto/ID27802
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a Scaffold for the Synthesis of Inhibitors of Bcr-Abl. (Articolo in rivista)
- Type
- Label
- N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a Scaffold for the Synthesis of Inhibitors of Bcr-Abl. (Articolo in rivista) (literal)
- Anno
- 2011-01-01T00:00:00+01:00 (literal)
- Alternative label
Arioli F, Borrelli S, Colombo F, Falchi F, Filippi I, Crespan E, Naldini A, Scalia G, Silvani A, Maga G, Carraro F, Botta M, Passarella D. (2011)
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a Scaffold for the Synthesis of Inhibitors of Bcr-Abl.
in ChemMedChem (Print)
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Arioli F, Borrelli S, Colombo F, Falchi F, Filippi I, Crespan E, Naldini A, Scalia G, Silvani A, Maga G, Carraro F, Botta M, Passarella D. (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Note
- ISI Web of Science (WOS) (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- [a] Dr. F. Arioli, Dr. S. Borrelli, Dr. F. Colombo, Dr. A. Silvani,
Prof. Dr. D. Passarella
Dipartimento di Chimica Organica e Industriale
Universit? degli Studi di Milan
Via G. Venezian 21, 20133 Milano (Italy)
E-mail: daniele.passarella@unimi.it
[b] Dr. F. Falchi, Prof. Dr. M. Botta
Dipartimento Farmaco Chimico Tecnologico
Universit? degli Studi di Siena, Via A. Moro, 53100 Siena (Italy)
[c] Dr. I. Filippi, Dr. A. Naldini, Dr. G. Scalia, Prof. Dr. F. Carraro
Dipartimento di Fisiologia
Universit? degli Studi di Siena, Via A. Moro, 53100 Siena (Italy)
[d] Dr. E. Crespan, Dr. G. Maga
Istituto di Genetica Molecolare IGM-CNR
Via Abbiategrasso 207, 27100 Pavia (Italy) (literal)
- Titolo
- N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a Scaffold for the Synthesis of Inhibitors of Bcr-Abl. (literal)
- Abstract
- N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine derivatives were synthesized and evaluated in vitro for their potential use as inhibitors of Bcr-Abl. The design is based on the bioisosterism between the 1,2,3-triazole ring and the amide group. The synthesis involves a copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) as the key step, with the exclusive production of anti-(1,4)-triazole derivatives. One of the compounds obtained shows general activity similar to that of imatinib; in particular, it was observed to be more effective in decreasing the fundamental function of cdc25A phosphatases in the K-562 cell line. (literal)
- Prodotto di
- Autore CNR
Incoming links:
- Prodotto
- Autore CNR di
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi